77 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
24 May 24
Avalon GloboCare Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
5:10pm
) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision … GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role
8-K
EX-99.1
44pncrv e5gb
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
8-K
EX-99.1
m7o3x64 g8ws5932a
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
EX-99.1
iudzk enxvnl79
19 Jul 23
Regulation FD Disclosure
9:21am
424B3
oonwt
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
a9lj2bu3etf3p54 rd
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
gklxx5i7c4hwdd
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
xdwdhj
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
8-K
EX-99.1
3sd62i5
14 Dec 22
Entry into a Material Definitive Agreement
9:18am
DEFA14A
lsethipbz75s
12 Dec 22
Additional proxy soliciting materials
10:41am
8-K
EX-99.1
y09j6clgb
8 Nov 22
Entry into a Material Definitive Agreement
9:15am